Startup | December 27, 2021
Healthcare start-up Zorgers raises angel round
The Home Healthcare market is expected to be US $ 14.2 by 2025
The Home Healthcare market is expected to be US $ 14.2 by 2025
The single-dose vaccine has been approved in China, Mexico, Ecuador, Chile, Argentina, Hungary, Kirghizstan, Pakistan, Indonesia and Malaysia
The authorization provides an additional treatment option against the Covid-19 virus in the form of a pill that can be taken orally
Pfizer raises production projections from 80 million to 120 million courses of treatment in 2022, as a result of continued investments to support the manufacturing and distribution of Paxlovid
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
Innovative market development collaboration also signed, expanding the availability of select Novartis oncology products in regions across China currently not covered by Novartis
The surgery was helmed by Prof. Dr. Vishwanath Pai, Sr. Consultant, Department of Minimally Invasive Surgery, Prashanth Hospitals, Velachery
Effectiveness of Covaxin against the Omicron variant is currently being studied
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
Vakrangee through its Nextgen Kendras and BharatEasy Mobile Superaap will now be able to provide medicines & healthcare services in remote areas of the country
Subscribe To Our Newsletter & Stay Updated
